{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","summary":"Apellis Pharmaceuticals is a commercial-stage biopharmaceutical company focused on discovery, development, and commercialization of therapeutic compounds targeting the complement system. It markets two FDA-approved drugs: SYFOVRE (pegcetacoplan injection) for geographic atrophy secondary to AMD, launched March 2023, and EMPAVELI (pegcetacoplan) for paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy. For 2025, SYFOVRE generated $586.9 million and EMPAVELI $102.4 million in U.S. net product revenue.","people":[],"products":[{"name":"SYFOVRE (pegcetacoplan injection)","type":"service","description":"FDA-approved intravitreal injection for geographic atrophy secondary to age-related macular degeneration; also approved in Australia January 2025."},{"name":"EMPAVELI (pegcetacoplan)","type":"service","description":"FDA-approved subcutaneous injection for paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy/primary IC-MPGN."},{"name":"APL-3007","type":"platform","description":"siRNA in Phase 2 combination trial with SYFOVRE aimed at blocking complement activity in the retina and choroid for GA."},{"name":"APL-9099","type":"platform","description":"Preclinical gene editing treatment targeting neonatal Fc receptor (FcRn), developed in collaboration with Beam Therapeutics."}],"partnerships":[{"partner_name":"Swedish Orphan Biovitrum AB (Sobi)","partnership_type":"licensing","description":"Sobi holds exclusive ex-U.S. commercialization rights for systemic pegcetacoplan (Aspaveli); July 2025 Royalty Buy-Down Agreement reduced Sobi royalties 90% for $275M upfront plus up to $25M milestone.","start_date":null},{"partner_name":"Beam Therapeutics, Inc.","partnership_type":"development","description":"Collaboration to develop gene editing pipeline candidates including APL-9099 targeting FcRn, with preclinical studies commenced.","start_date":null}],"affiliations":[],"origin":{"leaf":"a332f83eaf09e3f6db5c12d12d0b2536aeadcb6a1654eea0e4489358c5ead585","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"c474f731a558ddabbceee1ba04ce9021da6f2b17374271722cfee3c9864dc7c4","parent":"528c6df5d29267d9e48da59df4d49f23d7aa44048a190d3d0a89ff529dd6b685","source":"0001193125-26-065179","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":29,"hourly_limit":500,"remaining":471,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}